BioScrip to Present at the Jefferies 2017 Global Healthcare Conference
24 Mai 2017 - 2:00PM
BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a
leading national provider of infusion and home care management
solutions, today announced that Daniel E. Greenleaf, President and
Chief Executive Officer, and Stephen M. Deitsch, Senior Vice
President, Chief Financial Officer and Treasurer will present at
the Jefferies 2017 Global Healthcare Conference on Wednesday, June
7, 2017, at 4:00 p.m. EDT.
A live webcast of the presentation and copies of
the materials presented can be accessed via BioScrip’s Investor
Relations website at https://www.bioscrip.com/investors or through
the following link http://wsw.com/webcast/jeff105/bios.
About BioScrip
BioScrip, Inc. is a leading national provider of
infusion and home care management solutions. BioScrip partners with
physicians, hospital systems, skilled nursing facilities,
healthcare payors, and pharmaceutical manufacturers to provide
patients access to post-acute care services. BioScrip operates with
a commitment to bring customer-focused pharmacy and related
healthcare infusion therapy services into the home or
alternate-site setting. By collaborating with the full spectrum of
healthcare professionals and the patient, BioScrip provides
cost-effective care that is driven by clinical excellence, customer
service, and values that promote positive outcomes and an enhanced
quality of life for those it serves.
Investor Contacts:
Stephen Deitsch
Chief Financial Officer & Treasurer
T: (720) 697-5200
stephen.deitsch@bioscrip.com
David Clair
ICR, Inc.
T: (646) 277-1266
david.clair@icrinc.com
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024
Real-Time news about BioPlus Acquisition Corporation (NASDAQ): 0 recent articles
Plus d'articles sur